The FACC Advisory on Statins
In response to an increased number of inquiries from ACC members regarding how to respond to patient reaction to Baycol's withdrawal from the market and to inquiries on the general safety of statins, the College, in conjunction with the American Heart Association, has developed an advisory, which was distributed to the media Aug. 30.
The College has also developed a FAQ sheet for members and other physicians to use as a guide in discussions with patients. In addition, the College is considering whether a brief scientific statement designed to provide members with more specific information would be appropriate. Your input on the usefulness of such a document would be appreciated.
The College will continue to monitor this issue and will make every attempt to respond as necessary and in support of member and patient needs. All members are encouraged to contact the College to offer feedback on this effort and the issue in general. Please send your feedback to statins@acc.org
New | About Us | Services | Cardiac Diagnostic Center
Primary Care Doctor Info | Insurance & Billing | Locations
©Cardiology Consultants P.A. All rights reserved.
Website by Iron Monkey Interactive
